Search
Now showing items 1-7 of 7
Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry
(2020)
Abstract:
Atrial fibrillation (AF) is associated with substantially increased risk of cardiovascular events and overall mortality. The Atrial fibrillation Better Care (A—Avoid stroke, B—Better symptom management, ...
One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry
(2020)
Background: Atrial fibrillation (AF) poses a great risk of mortality, especially when associated with diabetes mellitus (DM). OBJECTIVES: We aimed to investigate the rate and risk factors for mortality among AF patients ...
One-year risks of stroke and death in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
(2019)
Background:
AF patients from different clinical settings may have varying outcomes. We aimed to provide patient-level comparisons using two cohorts of patients with AF from different settings.
Purpose:
We aimed to ...
The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry
(2022-11)
Abstract:
Background: The prognostic impact of obesity on patients with atrial fibrillation (AF) remains under-evaluated and controversial.
Methods:
Patients with AF from the Gulf Survey of Atrial Fibrillation Events ...
Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry)
(2021)
Abstract:
Atrial fibrillation (AF) is often asymptomatic. The prognosis of asymptomatic AF is at least similar or worse than symptomatic AF, but there are no such data from Middle East patients with AF. The Gulf-SAFE (Gulf ...
Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East
(2016)
Objective: The use of digoxin in patients having atrial fibrillation (AF) with or without heart failure (HF) is not without controversy. The aim of this study was to examine the impact of digoxin therapy on mortality ...
Ventricular Tachyarrhythmias in PatientsWith Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications
(2017-05)
Introduction: Triggers and ICD interventions of ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM) offer insight into mechanisms and treatment.
Methods and Results: Intracardiac ICD electrograms ...